NextCell Sverige AB
559496-7282ActiveDeveloping revolutionary stem cell therapies for autoimmune diseases.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2024
- Founded
Key Decision Makers
Mathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Mathias Svahn
CEO
+9 more contacts in Funnelfeedr
Description
NextCell Pharma is a Swedish biotechnology company focused on revolutionizing treatments for severe and incurable diseases using stem cell therapies. The company operates three main business areas: ProTrans, Cellaviva, and QVance, all centered around advanced therapy medicinal products (ATMPs). Thei...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- Aktiebolag
- VAT Number
- SE559496728201
Decision Makers
13 contacts in FunnelfeedrMathias Svahn
Chief Executive Officer
Eric Gustafsson
CFO
Lindsay Davies
CSO / CEO of QVance
Mathias Svahn
CEO
Camilla Myhre Sandberg
Board Member
Hans-Peter Ekre
Chairman of the Board
Sofie Falk Jansson
CEO of Cellaviva
Eva Sjökvist Saers
Board Member
Sofia Sisay
Head of Clinical Trials
Edvard Smith
Medical Director
Other Contacts
Per-Ola Carlsson
Advisor
Eric Strati
Advisor
Angela Vollstedt
Advisor
Similar Companies
20 similar companies in FunnelfeedrCellaviva AB
5–9 employeesScandinavia's largest private bank storing family stem cells for future health.
QVance AB
1–4 employeesSpecialist quality control analytics provider for cell and gene therapies.
CELLINK Bioprinting AB
20–49 employeesLeading provider of advanced 3D bioprinting systems and biomaterials.
Fluicell AB
10–19 employeesDeveloping precision-engineered tissues using single-cell bioprinting technology.
Xintela AB
10–19 employeesDeveloping stem cell and targeted cancer therapies for unmet needs.
NextCell Sverige AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo